Tandem Diabetes Care (TNDM) Revenue (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Revenue came in at $247.2 million in Q1 2026, up 5.46% YoY from $234.4 million in Q1 2025, and down 14.86% on a QoQ basis from $290.4 million in Q4 2025.
Tandem Diabetes Care (TNDM) Revenue (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Revenue data on file, last reported at $247.2 million in Q1 2026.
- Quarterly Revenue rose 5.46% year-over-year to $247.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 4.54% YoY) and the FY2025 annual result came in at $1.0 billion, up 7.93% from the prior year.
- Revenue retreated to $247.2 million in Q1 2026, from $290.4 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $290.4 million in Q4 2025 to a low of $169.4 million in Q1 2023.
- A 5-year average of $220.7 million and a median of $220.5 million in 2022 frame the typical range for Revenue.
- Annual changes were most pronounced in 2023 — Revenue declined 10.75% — and 2024, when it soared 43.62%.
- Tracing TNDM's Revenue over 5 years: stood at $220.5 million in 2022, then slipped by 10.75% to $196.8 million in 2023, then jumped by 43.62% to $282.6 million in 2024, then grew by 2.74% to $290.4 million in 2025, then retreated by 14.86% to $247.2 million in 2026.
- The last three Revenue figures came in at $247.2 million (Q1 2026), $290.4 million (Q4 2025), and $249.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 12.59 Bn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 6.59 Bn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 9.81 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 5.44 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 1.74 Bn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | 1.31 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 5.30 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 9.61 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 1.49 Bn |
| 10 | Tandem Diabetes Care | 1.60 Bn | 1.15 Bn | 144.78 Mn | 254.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 254.56 Mn |
| Mar 31, 2026 | 247.22 Mn |
| Dec 31, 2025 | 290.38 Mn |
| Sep 30, 2025 | 249.25 Mn |
| Jun 30, 2025 | 240.68 Mn |
| Mar 31, 2025 | 234.42 Mn |
| Dec 31, 2024 | 282.65 Mn |
| Sep 30, 2024 | 243.97 Mn |
| Jun 30, 2024 | 221.91 Mn |
| Mar 31, 2024 | 191.67 Mn |
| Dec 31, 2023 | 196.80 Mn |
| Sep 30, 2023 | 185.62 Mn |
| Jun 30, 2023 | 195.92 Mn |
| Mar 31, 2023 | 169.38 Mn |
| Dec 31, 2022 | 220.50 Mn |
| Sep 30, 2022 | 204.55 Mn |
| Jun 30, 2022 | 200.26 Mn |
| Mar 31, 2022 | 175.91 Mn |
| Dec 31, 2021 | 210.00 Mn |
| Sep 30, 2021 | 179.63 Mn |